⌘K

Login Start Free

Home/Filings/4/0001348362-20-000001

4//SEC Filing

DOCHERTY JOHN MARTIN 4

Accession 0001348362-20-000001

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Mar 23, 8:00 PM ET

Accepted

Mar 24, 12:56 PM ET

Size

9.6 KB

Accession

0001348362-20-000001

Insider Transaction Report

Form 4

Period: 2020-03-23

Lexaria Bioscience Corp.LXRP

DOCHERTY JOHN MARTIN

DirectorPresident

Transactions

Other
stock options
2020-03-23−400,000→ 850,000 total
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ common shares (400,000 underlying)

Holdings

stock options
Exercise: $0.11From: 2016-04-15Exp: 2021-04-15→ common shares (300,000 underlying)
300,000
stock options
Exercise: $1.53From: 2018-05-31Exp: 2023-05-31→ common shares (400,000 underlying)
700,000
common shares
(indirect: Private Holding Company)
1,622,250
stock options
Exercise: $0.47From: 2020-02-07Exp: 2025-02-07→ common shares (550,000 underlying)
1,250,000

Footnotes (1)

[F1]Cancellation of Options

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001638727

Filing Metadata

Form type: 4
Filed: Mar 23, 8:00 PM ET
Accepted: Mar 24, 12:56 PM ET
Size: 9.6 KB

View on SEC.gov